Fortress BiotechvsJohnson & Johnson

FBIO and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

FBIO

Fortress Biotech, Inc.

$1.82

Value $57M

+6.43%
FBIO's page

Fortress Biotech (FBIO) has a market value of $57M and Johnson & Johnson (JNJ) $672B. Over the last year, with dividends, FBIO moved -30.5% and JNJ +45.4%. Dividend yield: FBIO none, JNJ 1.89%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    FBIO$57M

    JNJ$672B

    JNJ is 11,766 times FBIO

  • Revenue, 12 months

    FBIO$70M

    JNJ$99.3B

    JNJ is 1,419 times FBIO

  • Net income, 12 months

    FBIO$100M

    JNJ$16.1B

    JNJ is 161 times FBIO

  • Operating margin

    FBIO-42.2%

    JNJ–

  • ROIC

    FBIO-14.7%

    JNJ12.4%

    27.1 points apart

  • P/E

    FBIO–

    JNJ41.7

  • Dividend yield

    FBIO0.0%

    JNJ1.9%

    1.9 points apart

  • 5-year return

    FBIO-96.3%

    JNJ+97.0%

    193.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

FBIO-96.3%

JNJ+97.0%

010020020222023202420252026
Returns by period
PeriodFBIOWith dividendsJNJWith dividends
1 year since November 14, 2025-30.5%Price -30.5%+45.4%Price +42.2%
3 years since November 17, 2023-12.9%-4.5% a yearPrice -12.9%+102.6%+26.5% a yearPrice +86.1%
5 years since November 16, 2021-96.3%-48.3% a yearPrice -96.3%+97.0%+14.5% a yearPrice +71.3%
10 years since November 17, 2016-95.1%-26.1% a yearPrice -95.1%+213.7%+12.1% a yearPrice +139.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

FBIOFortress BiotechJNJJohnson & Johnson

Valuation

FBIOJNJ
Valuation
Price$1.82$278.70
Market value$57M$672B
Enterprise value (EV)–$699B
P/E–41.7
P/E, 5-year median–21.9
P/B0.48.2
EV/EBIT–39.4
Free cash flow yield–3.1%

Results and growth

FBIOJNJ
Results and growth
Revenue, 12 months$70M$99.3B
Net income, 12 months$100M$16.1B
Free cash flow, 12 months$126M$20.6B
Earnings per share, 12 months$2.30$6.59
Revenue growth, year on year9.7%6.1%
Revenue growth a year, past+6.8%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

FBIOJNJ
Margins and returns on capital
Gross margin66.2%67.6%
Operating margin-42.2%–
Net margin143.1%16.2%
ROIC-14.7%12.4%
ROE84.6%19.7%

Balance sheet

FBIOJNJ
Balance sheet
Cash$152M$17.2B
Total debt–$44.7B
Net debt / EBITDA–1.1
Interest cover-3.2×18.0×

Dividends and buybacks

FBIOJNJ
Dividends and buybacks
Dividend yield–1.9%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield–0.9%
Shareholder yield–2.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: FBIO or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Fortress Biotech or Johnson & Johnson?

By market value, Johnson & Johnson ($672B) is about 11,766.1 times Fortress Biotech ($57M), at today's prices.

How did FBIO and JNJ stock do over the last 10 years?

Since November 17, 2016, FBIO's price moved -95.1% and JNJ's +139.1%. With dividends: FBIO -95.1% (-26.1% a year), JNJ +213.7% (+12.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, FBIO or JNJ?

The dividend yield at today's price is none for Fortress Biotech and 1.89% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

Which has the higher profit margins, Fortress Biotech or Johnson & Johnson?

Over the last twelve months, the net margin was 143.1% for Fortress Biotech and 16.2% for Johnson & Johnson, and the operating margin -42.2% and –. Revenue was $70M and $99.3B.

Which is the better investment, Fortress Biotech or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.